|
시장보고서
상품코드
2055186
구강 점막염 시장 : 원인별, 치료법별, 약제별, 중증도별, 환자 유형별, 유통 채널별, 최종사용자별, 지역별Oral Mucositis Market, By Cause, By Treatment Type, By Drug Type, By Severity Grade, By Patient Type, By Distribution Channel, By End User, By Geography |
||||||
구강 점막염 시장은 2026년에 18억 5,000만 달러로 추정되며, 2033년까지 30억 9,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 7.6%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 18억 5,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 7.60% | 2033년 시장 규모 예측 : | 30억 9,000만 달러 |
세계 구강 점막염 시장은 제약 및 헬스케어 산업에서 매우 중요한 분야로, 전 세계 수백만 명의 환자에게 영향을 미치는 중대한 미충족 의료 수요를 해결하고 있습니다. 구강 점막염은 구강 내를 덮고 있는 점막에 통증을 동반한 염증이나 궤양이 나타나는 것이 특징이며, 주로 화학요법, 방사선 요법, 표적 요법 등 암 치료의 심각한 부작용으로 발생합니다. 이러한 쇠약하게 만드는 증상은 치료법의 강도나 기간에 따라 다르지만, 치료를 받고 있는 암 환자의 약 40-100%에게 영향을 미치고 있습니다.
이 시장에는 구강 점막염의 중증도, 지속 기간 및 관련 합병증을 완화하기 위한 예방 조치, 지지 요법 제품, 혁신적인 치료법 등 다양한 치료 접근법이 포함되어 있습니다. 전 세계적으로 증가하는 암의 부담, 적극적인 암 치료 프로토콜의 보급, 그리고 지지 요법 관리에 대한 인식 제고에 힘입어, 이 시장은 종합적인 암 치료의 중요한 구성 요소로서의 입지를 확고히 하고 있습니다. 의료 종사자, 제약 회사 및 의료기기 제조업체들은 환자의 삶의 질, 치료 순응도, 그리고 전체 의료비에 중대한 영향을 미치는 이 증상을 해결하기 위한 효과적인 솔루션 개발에 점점 더 주력하고 있습니다.
시장 역학
세계 구강 점막염 시장은 주로 전 세계 암 발병률 증가에 힘입어 성장하고 있습니다. 세계보건기구(WHO) 등 여러 기관은 전 세계적으로 암 환자가 크게 증가할 것으로 전망하고 있으며, 이는 지지 요법 솔루션에 대한 수요 증가와 직접적인 상관관계가 있습니다. 고용량 화학요법 및 병용 요법을 포함한 암 치료 프로토콜의 강화로 인해 구강 점막염의 중증도와 발생 빈도가 높아지고 있으며, 이에 따라 치료적 개입에 대한 큰 시장 기회가 창출되고 있습니다. 암 치료에서 지지 요법의 중요성에 대한 의료 종사자와 환자의 인식이 높아지면서 시장 확산이 촉진되고 있으며, 한편으로는 선진국의 의료비 증가와 보험 급여 제도의 개선도 시장 성장을 뒷받침하고 있습니다.
그러나 시장에는 중대한 제약 요인도 존재합니다. 특히, 혁신적인 치료 솔루션의 높은 비용은 의료 예산이 여전히 제한적인 신흥국에서 접근성을 저해하는 요인이 되고 있습니다. 특정 지역의 의료 종사자들 사이에서 이용 가능한 치료 옵션에 대한 인식이 제한적일 뿐만 아니라, 의료 제도 간에 표준화된 치료 프로토콜이 부재한 점이 시장 침투를 저해하고 있습니다. 게다가 희귀질환이나 특정 질환을 대상으로 하는 의약품에 대한 복잡한 규제 환경은 신규 시장 진출기업에게 장벽이 되어 제품 승인을 지연시키고 있습니다. 그럼에도 불구하고, 생물학적 제제, 표적 치료, 그리고 효능과 환자 순응도 향상을 약속하는 혁신적인 전달 시스템을 포함한 새로운 치료 접근법의 개발을 통해 큰 기회가 존재합니다. 새로운 항암제 및 면역요법을 포함한 확대되는 종양학 파이프라인은 동반 치료 및 지원 치료 제품에 대한 기회를 제공합니다. 또한, 연구개발 투자 증가, 맞춤형 의료 접근법에 대한 관심 고조, 그리고 병용 요법의 가능성은 이 중요한 미충족 의료 수요를 해결하려는 시장 진출기업들에게 큰 성장 기회를 제공합니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표를 바탕으로 전 세계 구강 점막염 시장의 주요 기업 프로파일을 작성하였습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 구강 점막염 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 구강 점막염 시장 : 원인별, 2021년-2033년
제5장 세계의 구강 점막염 시장 : 치료 유형별, 2021년-2033년
제6장 세계의 구강 점막염 시장 : 약제 유형별, 2021년-2033년
제7장 세계의 구강 점막염 시장 : 중증도별, 2021년-2033년
제8장 세계의 구강 점막염 시장 : 환자 유형별, 2021년-2033년
제9장 세계의 구강 점막염 시장 : 유통 채널별, 2021년-2033년
제10장 세계의 구강 점막염 시장 : 최종사용자별, 2021년-2033년
제11장 세계의 구강 점막염 시장 : 지역별, 2021년-2033년
제12장 경쟁 구도
제13장 애널리스트의 제안
제14장 참고 문헌 및 조사 방법
LSH 26.06.22Oral Mucositis Market is estimated to be valued at USD 1.85 Bn in 2026 and is expected to reach USD 3.09 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.85 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.60% | 2033 Value Projection: | USD 3.09 Bn |
The global oral mucositis market represents a critical segment within the pharmaceutical and healthcare industry, addressing a significant unmet medical need affecting millions of patients worldwide. Oral mucositis, characterized by painful inflammation and ulceration of the mucous membranes lining the oral cavity, primarily occurs as a severe side effect of cancer treatments including chemotherapy, radiation therapy, and targeted therapies. This debilitating condition affects approximately 40-100% of cancer patients undergoing treatment, depending on the therapeutic regimen's intensity and duration.
The market encompasses various therapeutic approaches including preventive measures, supportive care products, and innovative treatment modalities designed to reduce the severity, duration, and associated complications of oral mucositis. The growing global cancer burden, increasing adoption of aggressive cancer treatment protocols, and rising awareness about supportive care management have positioned this market as a vital component of comprehensive oncology care. Healthcare providers, pharmaceutical companies, and medical device manufacturers are increasingly focusing on developing effective solutions to address this condition, which significantly impacts patient quality of life, treatment compliance, and overall healthcare costs.
Market Dynamics
The global oral mucositis market is primarily driven by the escalating global cancer incidence, with organizations like the World Health Organization projecting significant increases in cancer cases worldwide, directly correlating with higher the demand for supportive care solutions. The intensification of cancer treatment protocols, including high-dose chemotherapy regimens and combined modality treatments, has increased the severity and frequency of oral mucositis occurrences, creating substantial market opportunities for therapeutic interventions. Growing awareness among healthcare professionals and patients about the importance of supportive care in cancer treatment has enhanced market adoption, while increasing healthcare expenditure and improved reimbursement policies in developed nations support market growth.
However, the market faces significant restraints including the high cost of innovative therapeutic solutions, which limits accessibility particularly in emerging economies where healthcare budgets remain constrained. Limited awareness about available treatment options among healthcare providers in certain regions, coupled with the lack of standardized treatment protocols across different healthcare systems, hampers market penetration. Additionally, the complex regulatory landscape for pharmaceutical products targeting rare or specific conditions creates barriers for new market entrants and delays product approvals. Nevertheless, substantial opportunities exist through the development of novel therapeutic approaches including biologics, targeted therapies, and innovative delivery systems that promise enhanced efficacy and patient compliance. The expanding oncology pipeline with new chemotherapy agents and immunotherapies presents opportunities for companion supportive care products. Furthermore, increasing investments in research and development, growing focus on personalized medicine approaches, and the potential for combination therapies offer significant growth prospects for market participants in addressing this critical unmet medical need.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global oral mucositis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Amgen Inc, Helsinn Healthcare SA, Bausch Health Companies Inc, Spectrum Pharmaceuticals Inc, BioAlliance Pharma SA, STADA Arzneimittel AG, Soligenix Inc, OraPharma Inc, Innovation Pharmaceuticals Inc, EpicentRx Inc, Galera Therapeutics Inc, Pfizer Inc, Merck & Co, Biocon Limited, and OncoZenge AB
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global oral mucositis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oral mucositis market
Market Segmentation
- Cause Insights (Revenue, USD Bn, 2021 - 2033)
- Chemotherapy-Induced Oral Mucositis
- Radiotherapy-Induced Oral Mucositis
- Hematopoietic Stem Cell Transplantation-Induced Oral Mucositis
- Other Causes
- Treatment Type Insights (Revenue, USD Bn, 2021 - 2033)
- Barrier/Coating Agents (Gels, Mouthwashes, Sprays, Films)
- Analgesics and Anesthetics (Topical Analgesics, Topical Anesthetics)
- Anti-Inflammatory Agents (Steroidal, Non-Steroidal)
- Antimicrobials (Antifungals, Antibacterials)
- Growth Factors (Palifermin)
- Cryotherapy Devices (Intraoral Cryotherapy Devices)
- Nutritional Support Products (Oral Nutritional Supplements)
- Others
- Drug Type Insights (Revenue, USD Bn, 2021 - 2033)
- Small Molecule Drugs
- Biologics
- Biosimilars
- Severity Grade Insights (Revenue, USD Bn, 2021 - 2033)
- Mild (Grade 1-2)
- Severe (Grade 3-4)
- Patient Type Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adult
- Geriatric
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Dental Clinics
- Oncology Hospitals
- Research and Academic Institutes
- Homecare Settings
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Amgen Inc
- Helsinn Healthcare SA
- Bausch Health Companies Inc
- Spectrum Pharmaceuticals Inc
- BioAlliance Pharma SA
- STADA Arzneimittel AG
- Soligenix Inc
- OraPharma Inc
- Innovation Pharmaceuticals Inc
- EpicentRx Inc
- Galera Therapeutics Inc
- Pfizer Inc
- Merck & Co
- Biocon Limited
- OncoZenge AB
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Oral Mucositis Market, By Cause
- Global Oral Mucositis Market, By Treatment Type
- Global Oral Mucositis Market, By Drug Type
- Global Oral Mucositis Market, By Severity Grade
- Global Oral Mucositis Market, By Patient Type
- Global Oral Mucositis Market, By Distribution Channel
- Global Oral Mucositis Market, By End User
- Global Oral Mucositis Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Oral Mucositis Market, By Cause, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Chemotherapy-Induced Oral Mucositis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Radiotherapy-Induced Oral Mucositis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hematopoietic Stem Cell Transplantation-Induced Oral Mucositis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Causes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Oral Mucositis Market, By Treatment Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Barrier/Coating Agents (Gels, Mouthwashes, Sprays, Films)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Analgesics and Anesthetics (Topical Analgesics, Topical Anesthetics)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Anti-Inflammatory Agents (Steroidal, Non-Steroidal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Antimicrobials (Antifungals, Antibacterials)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Growth Factors (Palifermin)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cryotherapy Devices (Intraoral Cryotherapy Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nutritional Support Products (Oral Nutritional Supplements)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Oral Mucositis Market, By Drug Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Small Molecule Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biosimilars
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Oral Mucositis Market, By Severity Grade, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Mild (Grade 1-2)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Severe (Grade 3-4)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Oral Mucositis Market, By Patient Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Oral Mucositis Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Oral Mucositis Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Dental Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Oncology Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Oral Mucositis Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Cause, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Severity Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Cause, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Severity Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Cause, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Severity Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Cause, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Severity Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Cause, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Severity Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Cause, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Severity Grade, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Amgen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Helsinn Healthcare SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bausch Health Companies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Spectrum Pharmaceuticals Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioAlliance Pharma SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- STADA Arzneimittel AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Soligenix Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- OraPharma Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Innovation Pharmaceuticals Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- EpicentRx Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Galera Therapeutics Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biocon Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- OncoZenge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
